These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 619223)

  • 1. Tests for cataglykin activity on a cyanogen bromide fragment of human growth hormone.
    Schwartz PL; McHugh NJ
    Metabolism; 1978 Jan; 27(1):1-4. PubMed ID: 619223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-terminal peptide of growth hormone enhances insulin action in normal rats.
    Mondon CE; Reaven GM; Ling N; Lewis UJ; Frigeri LG
    Endocrinology; 1988 Aug; 123(2):827-33. PubMed ID: 3135175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic action of a novel constrained analog of human growth hormone-(6-13).
    Lim N; Ng FM; Wu ZM; Ede N; Hearn MT
    Endocrinology; 1992 Aug; 131(2):835-40. PubMed ID: 1639027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic effect of a hypoglycaemic fragment of human growth hormone (hGH 6-13).
    Ng FM; Rotstein T
    Diabetes Res; 1988 Mar; 7(3):103-8. PubMed ID: 3046817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats.
    Salem MA
    Endocrinology; 1988 Sep; 123(3):1565-76. PubMed ID: 3042372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemic action of synthetic C-terminal fragments of human growth hormone.
    Ng FM; Bornstein J
    Am J Physiol; 1978 May; 234(5):E521-6. PubMed ID: 645904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The minimal amino acid sequence of the insulin-potentiating fragments of human growth hormone: its mechanism of action.
    Ng FM; Bornstein J; Pullin CE; Bromley JO; Macaulay SL
    Diabetes; 1980 Oct; 29(10):782-7. PubMed ID: 6777219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of insulin receptor tyrosine kinase activity by an amino terminal sequence of human growth hormone.
    Lim N; Wijaya E; Ng F
    Life Sci; 1994; 54(20):1471-81. PubMed ID: 8190022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute effects of growth hormone on amino acid transport and protein synthesis are due to its insulin-like action.
    Cameron CM; Kostyo JL; Adamafio NA; Brostedt P; Roos P; Skottner A; Forsman A; Fryklund L; Skoog B
    Endocrinology; 1988 Feb; 122(2):471-4. PubMed ID: 3276499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an antilipogenic fragment of human growth hormone on glucose transport in rat adipocytes.
    Wijaya E; Ng FM
    Biochem Mol Biol Int; 1993 Nov; 31(3):543-52. PubMed ID: 8118430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-potentiating action of human growth hormone. Synthesis and activity of N-terminal fragments.
    Pullin CO; Harcourt JA; Ng FM; Bornstein J
    Int J Pept Protein Res; 1981 Sep; 18(3):318-23. PubMed ID: 7042618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel insulin-like actions of human growth hormone and its part sequence hGH 7-13.
    Armstrong JM; Bornstein J; Bromley JO; Macaulay SL; Ng FM
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):492-8. PubMed ID: 6405571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of insulin-potentiating fragments of human growth hormone by computative simulation; essential unit for insulin-involved biological responses.
    Ohkura K; Hori H
    Bioorg Med Chem; 2000 Jul; 8(7):1733-40. PubMed ID: 10976521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of constrained peptide analogues related to the N-terminal region of human growth hormone.
    Ede NJ; Lim N; Rae ID; Ng FM; Hearn MT
    Pept Res; 1991; 4(3):171-6. PubMed ID: 1823187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of C-terminal chain shortening on the insulin-antagonistic activity of human growth hormone 177--191.
    Wade JD; Ng FM; Bornstein J; Pullin CO; Pearce JS
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):10-4. PubMed ID: 6751009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-potentiating action of a synthetic amino-terminal fragment of human growth hormone (hGH 1--15) in streptozotocin-diabetic rats.
    Ng FM; Bornstein J
    Diabetes; 1979 Dec; 28(12):1126-30. PubMed ID: 510810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in vivo.
    Ng SF; Storlien LH; Kraegen EW; Stuart MC; Chapman GE; Lazarus L
    Metabolism; 1990 Mar; 39(3):264-8. PubMed ID: 2407927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and somatomedin activity of bovine growth hormone fragment 87-124.
    Liberti JP
    Biochim Biophys Acta; 1981 Jul; 675(2):239-47. PubMed ID: 7272336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of synthetic C-terminal fragments of hGH on insulin release by isolated islets.
    Weerasinghe C; Bornstein J
    Am J Physiol; 1978 May; 234(5):E527-31. PubMed ID: 206156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human growth hormone fragment (hGH44-91) produces insulin resistance and hyperinsulinemia but is less potent than 22 kDa hGH in the rat.
    Hettiarachchi M; Watkinson A; Leung KC; Sinha YN; Ho KK; Kraegen EW
    Endocrine; 1997 Feb; 6(1):47-52. PubMed ID: 9225115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.